Pfizer/BioNTech mRNA Combo Influenza and COVID Shot Efficacy Fails in Trial
Pfizer and BioNTech recently announced that a new mRNA vaccine designed to protect against both COVID-19 and influenza in a single shot faced a major setback after failing to achieve one of its primary goals in a late-stage trial. The “primary goal” missed in the late-stage trials was the ability to effectively prevent influenza B. […]
Risk of Infection Increases With Each mRNA COVID-19 Vaccine Dose, Study Shows
New research raises serious questions about the COVID-19 vaccine’s long-term effectiveness and potential role in increasing susceptibility to infection. In a recent peer-reviewed study published in Clinical Infectious Diseases, researchers found that the risk of COVID-19 increased as the number of vaccine doses increased and the vaccine became increasingly less effective against variants different from those […]
Vaccines, Doses & Shots. Confused?
In a phone conversation with Robert F. Kennedy, Jr. regarding childhood vaccinations last month, Donald Trump said: When you feed a baby, Bobby, a vaccination that is, like, 38 different vaccines and it looks like it’s been for a horse. Not a, you know, 10-pound or 20-pound baby. And then you see the baby all […]
Reports of Eye Disorders Spike After COVID Shots
In 2021, the World Health Organization’s (WHO) European drug monitoring system known as Vigibase, maintained by the Uppsala Monitoring Centre (UMC) in Sweden, received 19,916 reports of eye disorders following administration of COVID-19 shots. Vigibase had never recorded such a big spike in eye disorders until these biologics were introduced into the European market.1 Eye […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]
Monkeypox Fear Fest: Is Smallpox Vaccine on Its Way Back?
This article is an excerpt from a longer fully referenced report by NVIC co-founder and president Barbara Loe Fisher on Mutated Monkeypox Outbreaks and the Anticipated Return of Smallpox Vaccine, which can be read on NVIC.org. A day before the July 4, 2024 holiday, Business Insider published an article warning that “Experts are racing to […]